Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07055880 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Immunogenicity and Safety of Different Dosages of Rabies Vaccine (Serum-free Vero Cell)

StatusNot Yet Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated July 9, 2025 (before its estimated January 15, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
To describe the immunogenicity and safety of two dosages of Sinovac rabies vaccine, as well as compared the differences with the marked WHO PQ rabies vaccine Verorab® in a post-exposure prophylaxis (PEP) schedule.
Trial Details
NCT Number NCT07055880
Lead Sponsor Sinovac Biotech Co., Ltd
Conditions
(from sponsor)		 Rabies
Related terms Rabies
Enrollment 120 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov